ArticleJournal of translational medicine2025

Gp350-targeted CAR-T therapy in EBV-positive Burkitt lymphoma: pre-clinical development of gp350 CAR-T.

Jiajia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.